| #94 |
Derek Anthony Rawlings |
Smithkline & French Laboratories |
6 |
| #94 |
Alexander Humphries |
Merck |
6 |
| #94 |
Diana Hodgins |
British Aerospace Public Limited |
6 |
| #94 |
Jaroslaw Michal Szary |
Ossianix |
6 |
| #94 |
Arie Wijnen |
Dcs Copy Protection Limited |
6 |
| #94 |
Trevor Anthony Kenneth Wattam |
Glaxo Group Limited |
6 |
| #94 |
Ekaterini Kotsopoulou |
Autolus Limited |
6 |
| #94 |
Hawa Diallo |
Glaxo Group Limited |
6 |
| #94 |
Peter R. Watson |
Xerox |
6 |
| #94 |
Heather Hobbs |
Smithkline Beecham Limited |
6 |
| #94 |
Anthony Machell |
Mbda Uk Limited |
6 |
| #94 |
Mary Kerr |
Kandy Therapeutics Limited |
6 |
| #94 |
Graham Dew |
Airbus Defence And Space Gmbh |
6 |
| #114 |
Andrew Theophilus |
Smithkline Beecham Limited |
5 |
| #114 |
Robert David Willacy |
Glaxo Group Limited |
5 |
| #114 |
Francis Louis Atkinson |
Glaxo Group Limited |
5 |
| #114 |
Robert William Lancaster |
Smithkline Beecham Limited |
5 |
| #114 |
Rabinder Kumar Prinjha |
Glaxo Group Limited |
5 |
| #114 |
Chun-Wa Chung |
Glaxo Group Limited |
5 |
| #114 |
Daniel Terence Tape |
Glaxosmithkline Intellectual Property Development Limited |
5 |
| #114 |
Martin Anibal Orecchia |
Glaxosmithkline Intellectual Property Development Limited |
5 |
| #114 |
Derek William Judd |
Xerox |
5 |
| #114 |
Philip Charles Green |
Design Blue |
5 |
| #114 |
Christopher M. Potter |
Marconi Instruments Limited |
5 |
| #114 |
Steven Leslie Sollis |
Glaxo Group Limited |
5 |
| #114 |
David Horna Tomas |
Institut Quimic De Sarria Cets Fundacio Privada |
5 |
| #114 |
Hans Jakob Kristoffer Famm |
Galvani Bioelectronics Limited |
5 |
| #114 |
Rino Antonio Bit |
Glaxosmithkline Intellectual Property Development Limited |
5 |
| #114 |
Stephanie Jane Clegg |
Glaxo Group Limited |
5 |
| #114 |
Marina Tarunina |
Plasticell Limited |
5 |
| #114 |
Kexuan SUN |
Viavi Solutions |
5 |
| #132 |
Douglas Bisset |
Xerox |
4 |
| #132 |
Suzanne Joy Merrick |
Glaxo Group Limited |
4 |
| #132 |
Graeme Michael Robertson |
Glaxo Group Limited |
4 |
| #132 |
Christopher David Bevan |
Glaxo Group Limited |
4 |
| #132 |
Peter Kumpalume |
Bio Products Laboratory Limited |
4 |
| #132 |
Philip G. Humphreys |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| #132 |
John David Hayler |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| #132 |
Gianpaolo Bravi |
Glaxo Group Limited |
4 |
| #132 |
Juliet Kay Simpson |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| #132 |
Martin Edward Swarbrick |
Glaxo Group Limited |
4 |
| #132 |
Aurelie Cecile Champigny |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| #132 |
Jaime Reed |
Airbus Defence And Space Gmbh |
4 |
| #132 |
Robert Peter Law |
Glaxosmithkline Intellectual Property (No. 4) Limited |
4 |
| #132 |
John Alexander Brown |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| #132 |
Afjal Hussain Miah |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| #132 |
Mahmoud Mahmoudian |
Glaxo Group Limited |
4 |
| #132 |
Simon Peace |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| #132 |
Lena Shukla |
Glaxo Group Limited |
4 |
| #132 |
Christopher Kitson |
Glaxo Group Limited |
4 |